DON CARY PEARSON
Medical Practice in Tacoma, WA

License number
Pennsylvania MD008135E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address 2
Tacoma, WA 98405
Pennsylvania

Personal information

See more information about DON CARY PEARSON at radaris.com
Name
Address
Phone
Don Pearson, age 96
4102 NE 165Th Ave, Vancouver, WA 98682
Don Pearson
PO Box 533, Kettle Falls, WA 99141
Don Pearson, age 79
8618 131St Ave NE, Lake Stevens, WA 98258
Don Pearson, age 89
8468 Skagitwilde Ln, Concrete, WA 98237
Don Pearson, age 90
6708 Bridgeport Way W, Tacoma, WA 98499

Professional information

See more information about DON CARY PEARSON at trustoria.com
Don Pearson Photo 1
Unit Dosage Forms For Treatment Of Vasoconstriction And Related Conditions

Unit Dosage Forms For Treatment Of Vasoconstriction And Related Conditions

US Patent:
5849338, Dec 15, 1998
Filed:
Aug 26, 1997
Appl. No.:
8/849068
Inventors:
Kenneth T. Richardson - Anchorage AK
Don C. Pearson - Tacoma WA
Assignee:
ChronoRX LLC - Anchorage AK
International Classification:
A61K 3306, A61K 3304, A61K 31495, A61K 3150
US Classification:
424682
Abstract:
Magnesium is formulated in combination with vitamin E, vitamin C, folate, selenium, and optionally melatonin in a unit dosage form for oral administration, for the treatment of vasoconstriction and the physiological and pathological conditions giving rise to vasoconstriction. These active agents complement each other in suppressing these conditions, using a variety of mechanisms operating in conjunction with one another. The inclusion of magnesium in a plurality of forms provides additional advantages in terms of controlling and sustaining the release of magnesium in locations along the digestive tract where the magnesium will have its greatest effectiveness as a therapeutic agent, thus improving control over thge clinical bioavailability of magnesium and in improving the selection of appropriate therapeutic ranges.


Don Pearson Photo 2
Unit Dosage Forms For Treatment Of Vasoconstriction And Related Conditions

Unit Dosage Forms For Treatment Of Vasoconstriction And Related Conditions

US Patent:
6042849, Mar 28, 2000
Filed:
Jul 7, 1998
Appl. No.:
9/111055
Inventors:
Kenneth T. Richardson - Anchorage AK
Don C. Pearson - Tacoma WA
Assignee:
ChronoRX, LLC - Anchorage AK
International Classification:
A61K 31355, A61K 3134, A61K 3306, A61K 3304, A61K 31495, A61K 3150, A61K 3140
US Classification:
424682
Abstract:
Magnesium is formulated in combination with vitamin E, vitamin C, folate, selenium, and optionally melatonin a unit dosage form for oral administration, for the treatment of vasoconstriction and the physiological and pathological conditions giving rise to vasoconstriction. These active agents complement each other in suppressing these conditions, using a variety of mechanisms operating in conjunction with one another. The inclusion of magnesium in a plurality of forms provides additional advantages in terms of controlling and sustaining the release of magnesium in locations along the digestive tract where the magnesium will have its greatest effectiveness as a therapeutic agent, thus improving control over the clinical bioavailability of magnesium and in improving the selection of appropriate therapeutic ranges.